Description

(3S,5S,10S,13R,14S,17S)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2S,5R)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde is a high-purity, complex steroidal compound of significant interest in advanced pharmaceutical research and development. Its intricate molecular structure makes it a valuable key intermediate for synthesizing novel therapeutic agents, particularly in the fields of endocrinology and oncology. This compound is essential for R&D laboratories and production facilities focused on creating new steroid-based pharmaceuticals and exploring structure-activity relationships.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of novel steroid-based active pharmaceutical ingredients (APIs).
• Research & Development: Used in academic and industrial R&D for studying steroid biochemistry, receptor interactions, and metabolic pathways.
• Reference Standard: Employed as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Process Chemistry: Utilized in process development and scale-up activities for the manufacture of complex steroidal molecules.
• Drug Discovery: Acts as a precursor or template in medicinal chemistry programs aimed at developing new therapeutic candidates with modified biological activity.

Basic Information

Product Name	(3S,5S,10S,13R,14S,17S)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2S,5R)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
CAS No.	5822-57-1
Molecular Formula	C30H40O10
Molecular Weight	560.64 g/mol
Synonyms	Digitoxigenin β-D-digitaloside; Digoxigenin bisdigitoxoside; 3β-[(2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide; 3β-[(O-β-D-Digitoxosyl-(1→4)-β-D-digitoxosyl)oxy]-14-hydroxy-5β-card-20(22)-enolide; Digoxigenin bis-digitoxoside; 12-Hydroxydigitoxin genin bisdigitoxoside; Digoxigenin-β-D-digitaloside; Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-14-hydroxy-, (3β,5β)-
EINECS	Contact for details

Quality Control

Our (3S,5S,10S,13R,14S,17S)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2S,5R)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical intermediates. Certificates of Analysis (COA) detailing all test results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.